US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Midwives: State Industry Market Evaluator 621399.08
12/1/2014 | published by: BizMiner
... for 2011-2012-2013-2014q2 for these measures: industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, ...  |  read more...
USD 599
Abortion Information & Services: State Industry Market Evaluator 621410.01
12/1/2014 | published by: BizMiner
... Statistics are displayed for 2011-2012-2013-2014q2 for these measures: industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include ...  |  read more...
USD 599
Metastatic Breast Cancer - Pipeline Review, H2 2014
11/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Metastatic Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
10/30/2014 | published by: Kalorama Information
... maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific ...  |  read more...
USD 3,995
Epithelial Ovarian Cancer-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Epithelial Ovarian Cancer. This report provides information on the therapeutic development based on the Epithelial Ovarian Cancer dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Post Menopausal Osteoporosis-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Post Menopausal Osteoporosis. This report provides information on the therapeutic development based on the Post Menopausal Osteoporosis dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Premenstrual Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Premenstrual Syndrome. This report provides information on the therapeutic development based on the Premenstrual Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Primary Dysmenorrhea-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Primary Dysmenorrhea. This report provides information on the therapeutic development based on the Primary Dysmenorrhea dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Uterine Cancer-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Uterine Cancer. This report provides information on the therapeutic development based on the Uterine Cancer dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Uterine Fibroids-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Uterine Fibroids. This report provides information on the therapeutic development based on the Uterine Fibroids dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Vaginitis -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Vaginitis . This report provides information on the therapeutic development based on the Vaginitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase ...  |  read more...
USD 1,250
Vasomotor Symptoms of Menopause-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Vasomotor Symptoms of Menopause. This report provides information on the therapeutic development based on the Vasomotor Symptoms of Menopause dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
Global Pregnancy Detection Kit Market 2015-2019
11/26/2014 | published by: TechNavio - Infiniti Research Ltd.
... of the three categories under rapid pregnancy tests. The remaining two are the strip format and the card or cassette format. A pregnancy detection kit uses rapid chromatographic immunoassay technique for the detection of hCG ...  |  read more...
USD 2,500
Breast Cancer - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Women Infertility Global Clinical Trials Review, H2, 2014
11/17/2014 | published by: GlobalData
... information and data relating to the clinical trials on Women Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Breast Cancer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Ovarian Cancer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Primary Dysmenorrhea-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Vulvovaginal Candidiasis-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Women Infertility-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Hormone Refractory Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Primary Dysmenorrhea- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Female Sexual Dysfunction Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
< prev 1    3  4  5  6  7  8  9  10